Apogee Therapeutics (APGE) Other Accumulated Expenses (2022 - 2024)

Apogee Therapeutics (APGE) has reported Other Accumulated Expenses for 3 consecutive years, with $1.7 million the latest figure, recorded in Q3 2024.

• In Q3 2024, Other Accumulated Expenses rose 144.65% year-over-year to $1.7 million; the TTM figure through Sep 2024 stood at $1.7 million (up 144.65% YoY), while the FY2023 annual figure was $1.2 million, up 521.5% from the prior year.
• Other Accumulated Expenses climbed to $1.7 million in Q3 2024 per APGE's latest filing, from $1.0 million in the prior quarter.
• Across five years, Other Accumulated Expenses topped out at $2.1 million in Q1 2024 and bottomed at $200000.0 in Q4 2022.
• Historically, Other Accumulated Expenses has averaged $1.3 million across 3 years, with a median of $1.2 million in 2023.
• Annual changes were most pronounced in 2023 — Other Accumulated Expenses soared 521.5% — and 2024, when it sank 44.94%.
• Apogee Therapeutics' Other Accumulated Expenses stood at $200000.0 in 2022, then jumped by 521.5% to $1.2 million in 2023, then surged by 36.2% to $1.7 million in 2024.
• Business Quant data shows APGE's Other Accumulated Expenses at $1.7 million in Q3 2024, $1.0 million in Q2 2024, and $2.1 million in Q1 2024.